Page last updated: 2024-11-01

norfloxacin and Carcinoma, Squamous Cell

norfloxacin has been researched along with Carcinoma, Squamous Cell in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dupin, N1
Gerhardt, P1

Other Studies

1 other study available for norfloxacin and Carcinoma, Squamous Cell

ArticleYear
[Diagnosis of sexually transmitted diseases: case studies].
    Presse medicale (Paris, France : 1983), 2013, Volume: 42, Issue:4 Pt 1

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Diagn

2013